Fact CheckerSign in

NCT01961232Active, not recruiting

Trans-pulmonary Biomarkers in Pulmonary Hypertension

Examination of Trans-pulmonary Biomarkers in Pulmonary Hypertension: a Potential Step Towards Personalized Therapy

Source: ClinicalTrials.gov · Last updated 17 Mar 2026

Brief summary (registry, in English)

The investigators are testing whether the addition of Pulmonary Hypertension-related biomarkers, measured across the pulmonary circulation, to the standard hemodynamic evaluation for Pulmonary Hypertension will lead to more informed choices of Pulmonary Hypertension therapy and improved patient outcomes.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
100 (estimated)
First submitted
19 Sept 2013
Start date
Aug 2013
Primary completion date
Jan 2015
Lead sponsor
Vanderbilt University
NCT number
NCT01961232

What you commit to

  • Study type: Observational
  • Planned participants: 100
  • From Aug 2013 to the primary completion date, Jan 2015
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patient is currently taking PH medication or long-acting nitrates at the time of their RHC.

Lab values

  • Anemia defined as Hgb \< 10 g/dL and HCT \< 30
  • Pregnancy at the time of RHC (as assessed by urine or serum pregnancy test on the day of the procedure)
  • Left ventricular ejection fraction ≤ 40%

Other

  • Atrial fibrillation at the time of RHC (as defined by telemetry monitoring or EKG on the day of the procedure)
  • IPF, CTEPH, COPD/OSA as the dominant etiology of PH

Who the study is looking for

  • Age ≥ 18 years old
  • Undergoing RHC for PH evaluation

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vanderbilt University Medical Center
Coordinator of this site? Confirm its status
NashvilleUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.